Cargando…

ASCT2 (SLC1A5)-Deficient Mice Have Normal B-Cell Development, Proliferation, and Antibody Production

SLC1A5 (solute carrier family 1, member 5) is a small neutral amino acid exchanger that is upregulated in rapidly proliferating lymphocytes but also in many primary human cancers. Furthermore, cancer cell lines have been shown to require SLC1A5 for their survival in vitro. One of SLC1A5’s primary su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Masle-Farquhar, Etienne, Bröer, Angelika, Yabas, Mehmet, Enders, Anselm, Bröer, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427077/ https://www.ncbi.nlm.nih.gov/pubmed/28553292 http://dx.doi.org/10.3389/fimmu.2017.00549

Ejemplares similares

Disruption of Amino Acid Homeostasis by Novel ASCT2 Inhibitors Involves Multiple Targets
por: Bröer, Angelika, et al.
Publicado: (2018)

ATP11C Facilitates Phospholipid Translocation across the Plasma Membrane of All Leukocytes
por: Yabas, Mehmet, et al.
Publicado: (2016)

Expression of Glutamine Transporter Slc38a3 (SNAT3) During Acidosis is Mediated by a Different Mechanism than Tissue-Specific Expression
por: Balkrishna, Sarojini, et al.
Publicado: (2014)

Mice lacking neutral amino acid transporter B(0)AT1 (Slc6a19) have elevated levels of FGF21 and GLP-1 and improved glycaemic control
por: Jiang, Yang, et al.
Publicado: (2015)

Do Amino Acid Antiporters Have Asymmetric Substrate Specificity?
por: Gauthier-Coles, Gregory, et al.
Publicado: (2023)

Identification and characterization of a novel SNAT2 (SLC38A2) inhibitor reveals synergy with glucose transport inhibition in cancer cells
por: Gauthier-Coles, Gregory, et al.
Publicado: (2022)

Amino acid homeostasis and signalling in mammalian cells and organisms
por: Bröer, Stefan, et al.
Publicado: (2017)

Maternal heterozygosity of Slc6a19 causes metabolic perturbation and congenital NAD deficiency disorder in mice
por: Cuny, Hartmut, et al.
Publicado: (2022)

Mice Lacking the Intestinal and Renal Neutral Amino Acid Transporter SLC6A19 Demonstrate the Relationship between Dietary Protein Intake and Amino Acid Malabsorption
por: Javed, Kiran, et al.
Publicado: (2019)

Murine LRBA deficiency causes CTLA-4 deficiency in Tregs without progression to immune dysregulation
por: Burnett, Deborah L, et al.
Publicado: (2017)

CARD11 gain-of-function mutation drives cell-autonomous accumulation of PD-1(+) ICOS(high) activated T cells, T-follicular, T-regulatory and T-follicular regulatory cells
por: Masle-Farquhar, Etienne, et al.
Publicado: (2023)

Inhibition of GCN2 Reveals Synergy with Cell-Cycle Regulation and Proteostasis
por: Gauthier-Coles, Gregory, et al.
Publicado: (2023)

Intestinal peptidases form functional complexes with the neutral amino acid transporter B(0)AT1
por: Fairweather, Stephen J., et al.
Publicado: (2012)

D-Serine Is a Substrate for Neutral Amino Acid Transporters ASCT1/SLC1A4 and ASCT2/SLC1A5, and Is Transported by Both Subtypes in Rat Hippocampal Astrocyte Cultures
por: Foster, Alan C., et al.
Publicado: (2016)

Clinical Role of ASCT2 (SLC1A5) in KRAS-Mutated Colorectal Cancer
por: Toda, Kosuke, et al.
Publicado: (2017)

Case report: Sandwich therapy of CAR-T combined with ASCT: Sequential CAR-T cell therapy with ASCT after remission with CAR-T therapy caused long-term survival in a patient with relapsed/refractory Burkitt’s lymphoma with TP53 mutations
por: Zhang, Qi, et al.
Publicado: (2023)

ATP11c is critical for phosphatidylserine internalization and B lymphocyte differentiation
por: Yabas, Mehmet, et al.
Publicado: (2011)

Development of Biomarkers for Inhibition of SLC6A19 (B(0)AT1)—A Potential Target to Treat Metabolic Disorders
por: Javed, Kiran, et al.
Publicado: (2018)

Interaction of Cholesterol With the Human SLC1A5 (ASCT2): Insights Into Structure/Function Relationships
por: Scalise, Mariafrancesca, et al.
Publicado: (2019)

PKC-Mediated Modulation of Astrocyte SNAT3 Glutamine Transporter Function at Synapses in Situ
por: Dong, Wuxing, et al.
Publicado: (2018)

A GC-MS/Single-Cell Method to Evaluate Membrane Transporter Substrate Specificity and Signaling
por: Fairweather, Stephen J., et al.
Publicado: (2021)

Structural characterisation reveals insights into substrate recognition by the glutamine transporter ASCT2/SLC1A5
por: Scopelliti, Amanda J, et al.
Publicado: (2018)

Functional and Kinetic Comparison of Alanine Cysteine Serine Transporters ASCT1 and ASCT2
por: Wang, Jiali, et al.
Publicado: (2022)

Cryo-EM structures of the human glutamine transporter SLC1A5 (ASCT2) in the outward-facing conformation
por: Yu, Xiaodi, et al.
Publicado: (2019)

Quantitative modelling of amino acid transport and homeostasis in mammalian cells
por: Gauthier-Coles, Gregory, et al.
Publicado: (2021)

Amino Acid Transporters as Targets for Cancer Therapy: Why, Where, When, and How
por: Bröer, Stefan
Publicado: (2020)

The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5)
por: Cormerais, Yann, et al.
Publicado: (2018)

Low temperature bacterial expression of the neutral amino acid transporters SLC1A5 (ASCT2), and SLC6A19 (B0AT1)
por: Galluccio, Michele, et al.
Publicado: (2020)

The Human SLC1A5 (ASCT2) Amino Acid Transporter: From Function to Structure and Role in Cell Biology
por: Scalise, Mariafrancesca, et al.
Publicado: (2018)

ASCT2 (SLC1A5)-dependent glutamine uptake is involved in the progression of head and neck squamous cell carcinoma
por: Zhang, Ze, et al.
Publicado: (2019)

Knockout of the Amino Acid Transporter SLC6A19 and Autoimmune Diabetes Incidence in Female Non-Obese Diabetic (NOD) Mice
por: Waters, Matthew F., et al.
Publicado: (2021)

Ligand Discovery for the Alanine-Serine-Cysteine Transporter (ASCT2, SLC1A5) from Homology Modeling and Virtual Screening
por: Colas, Claire, et al.
Publicado: (2015)

ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer
por: van Geldermalsen, M, et al.
Publicado: (2016)

Novel Chemical Scaffolds to Inhibit the Neutral Amino Acid Transporter B(0)AT1 (SLC6A19), a Potential Target to Treat Metabolic Diseases
por: Yadav, Aditya, et al.
Publicado: (2020)

The Treatment of Multiple Myeloma Patients Not Eligible for Asct
por: Richardson, Paul, et al.
Publicado: (2010)

Autoimmune Lymphoproliferative Syndrome-FAS Patients Have an Abnormal Regulatory T Cell (Treg) Phenotype but Display Normal Natural Treg-Suppressive Function on T Cell Proliferation
por: Mazerolles, Fabienne, et al.
Publicado: (2018)

Predominantly Antibody-Deficient Patients With Non-infectious Complications Have Reduced Naive B, Treg, Th17, and Tfh17 Cells
por: Edwards, Emily S. J., et al.
Publicado: (2019)

ASCT2 overexpression is associated with poor survival of OSCC patients and ASCT2 knockdown inhibited growth of glutamine‐addicted OSCC cells
por: Luo, Yijun, et al.
Publicado: (2020)

Targeting ASCT2-mediated glutamine metabolism inhibits proliferation and promotes apoptosis of pancreatic cancer cells
por: Wang, Wenbin, et al.
Publicado: (2022)

Amino Acid Homeostasis in Mammalian Cells with a Focus on Amino Acid Transport
por: Bröer, Stefan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ikj5i9c6th4ue439pdi0vngndq